Aarti Drugs Limited has informed the Exchange about Crisil ESG rating
AARTIDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Drugs Limited has informed the stock exchange that it has received an ESG (Environmental, Social, and Governance) rating from Crisil. ESG ratings assess how well a company manages sustainability, social responsibility, and corporate governance practices. The specific rating score or grade was not disclosed in the headline. This is an informational disclosure rather than a credit rating, which means it does not directly impact the company's borrowing cost or debt status. Crisil is one of India's leading rating agencies and this disclosure is part of growing transparency around ESG metrics.
Likely neutral for short-term stock price; ESG ratings may matter to sustainability-focused investors and could support long-term institutional interest, but the headline does not indicate a rating change or financial implication.